These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36806726)
1. The NBN founder mutation-Evidence for a country specific difference in age at cancer manifestation. Chrzanowska KH; Seemanova E; Varon R; Digweed M; Piekutowska-Abramczuk D; Sperling K; Seeman P Cancer Rep (Hoboken); 2023 Feb; 6(2):e1700. PubMed ID: 36806726 [TBL] [Abstract][Full Text] [Related]
2. Cancer risk of heterozygotes with the NBN founder mutation. Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374 [TBL] [Abstract][Full Text] [Related]
3. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness? Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167 [TBL] [Abstract][Full Text] [Related]
4. [Heterozygous carriers of Slavic mutation 657del5 of NBN gene in patients with colorectal cancer]. Seemanová E; Hoch J; Seeman P Cas Lek Cesk; 2011; 150(2):97-9. PubMed ID: 21560448 [TBL] [Abstract][Full Text] [Related]
5. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation. Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933 [TBL] [Abstract][Full Text] [Related]
6. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation. Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873 [TBL] [Abstract][Full Text] [Related]
7. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions. Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123 [TBL] [Abstract][Full Text] [Related]
8. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. Seemanová E; Sperling K; Neitzel H; Varon R; Hadac J; Butova O; Schröck E; Seeman P; Digweed M J Med Genet; 2006 Mar; 43(3):218-24. PubMed ID: 16033915 [TBL] [Abstract][Full Text] [Related]
9. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients. Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051 [TBL] [Abstract][Full Text] [Related]
10. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation. Gładkowska-Dura M; Dzierzanowska-Fangrat K; Dura WT; van Krieken JH; Chrzanowska KH; van Dongen JJ; Langerak AW J Pathol; 2008 Nov; 216(3):337-44. PubMed ID: 18788073 [TBL] [Abstract][Full Text] [Related]
15. Telomere attrition and dysfunction: a potential trigger of the progeroid phenotype in nijmegen breakage syndrome. Habib R; Kim R; Neitzel H; Demuth I; Chrzanowska K; Seemanova E; Faber R; Digweed M; Voss R; Jäger K; Sperling K; Walter M Aging (Albany NY); 2020 Jun; 12(12):12342-12375. PubMed ID: 32564008 [TBL] [Abstract][Full Text] [Related]
16. Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland). Ziółkowska I; Mosor M; Nowak J J Appl Genet; 2006; 47(3):269-72. PubMed ID: 16877808 [TBL] [Abstract][Full Text] [Related]